Work

Morbidity and Mortality Outcomes of Dupilumab for Cutaneous Immune-Related Adverse Events

Year: 2026

Type: article

Abstract: This cohort study evaluates morbidity and mortality outcomes associated with dupilumab treatment in patients with cutaneous immune-related adverse events.

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2025.6092

Authors: Brandon R. Block, Jaanvi Mehta, Shayan Owji, Dan Feng, Thomas U. Marron, Nicholas Gulati

Institution: Icahn School of Medicine at Mount Sinai

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Award: Conduits: Mount Sinai Health System Translational Science Hub

OpenAlex ID: W7125378655

FWCI: 21.06

Cites: 5

Cited by: 8

Related to: